Pacira Biosciences Inc reports results for the quarter ended in June - Earnings Summary

Pacira Biosciences

02/08/2023 14:33

* Pacira Biosciences Inc  PCRX.OQ  reported quarterly
adjusted
earnings of 78 cents​​ per share for the quarter ended in June.
The mean expectation of nine analysts for the quarter was
for earnings of 76 cents per share.
    * Revenue rose 0% to $169.47 million from a year ago;
analysts
expected $174.60 million. 
    * Pacira Biosciences Inc's reported EPS for the quarter was
51
cents​.
    * The mean earnings estimate of analysts had fallen by
about 7.2%
in the last three months.​ 
    * In the last 30 days, five analysts negatively revised
earnings
estimates 
    * Pacira Biosciences Inc shares had fallen by 10.2% this
quarter and lost 6.8% so far this year.
    * The company reported quarterly net income of $25.76
million.
    * Wall Street's median 12-month price target for Pacira
Biosciences Inc is $60.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 2 at 01:33 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      0.76           0.78           Beat
 Mar. 31 2023      0.62           0.53           Missed
 Dec. 31 2022      0.83           0.80           Missed
 Sep. 30 2022      0.76           0.64           Missed